(Q45114552)

9 December 2017

Effects of SR 141716A after acute or chronic cannabinoid administration in dogs (English)

1 reference

9 December 2017

0 references

2

1 reference

9 December 2017

7

B R Martin

1 reference

9 December 2017

A H Lichtman

1

1 reference

9 December 2017

K L LaVecchia

3

1 reference

9 December 2017

S T Neviaser

4

1 reference

9 December 2017

D B Arthur

5

1 reference

9 December 2017

D M Wilson

6

1 reference

9 December 2017

language of work or name

English

0 references

publication date

1 September 1998

1 reference

European Journal of Pharmacology

9 December 2017

1 reference

9 December 2017

357

1 reference

9 December 2017

139-148

1 reference

9 December 2017

2-3

1 reference

Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A.

9 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900558-5

Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900558-5

Relationships between frequency and quantity of marijuana use and last year proxy dependence among adolescents and adults in the United States.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900558-5

Effects of anandamide on cannabinoid receptors in rat brain membranes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900558-5

Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900558-5

Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900558-5

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900558-5

Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900558-5

Clinical relevance of cannabis tolerance and dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900558-5

SR141716A is an inverse agonist at the human cannabinoid CB1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900558-5

Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900558-5

A three-state receptor model of agonist action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900558-5

Failure to obtain "cannabis-directed behavior" and abstinence syndrome in rats chronically treated with cannabis sativa extracts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900558-5

The selective cannabinoid antagonist SR 141716A blocks cannabinoid-induced antinociception in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900558-5

Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900558-5

Stereochemical effects of 11-OH-delta 8-THC-dimethylheptyl in mice and dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900558-5

The endogenous cannabinoid receptor agonist anandamide impairs memory in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900558-5

Pharmacological potency of R- and S-3′-hydroxy-Δ9-tetrahydrocannabinol: additional structural requirement for cannabinoid activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900558-5

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900558-5

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900558-5

Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900558-5

Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900558-5

Physical withdrawal in rats tolerant to delta 9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900558-5

Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900558-5

Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900558-5

Discriminative stimulus effects of anandamide in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900558-5

Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900558-5

Evaluation of cannabimimetic discriminative stimulus effects of anandamide and methylated fluoroanandamide in rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900558-5

9-Nor-.DELTA.8-tetrahydrocannabinol, a cannabinoid of metabolic interest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900558-5

Some 9-hydroxycannabinoid-like compounds. Synthesis and evaluation of analgesic and behavioral properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900558-5

(R)-methanandamide, but not anandamide, substitutes for delta 9-THC in a drug-discrimination procedure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900558-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(98)00558-5

1 reference

9 December 2017

1 reference